Translational Biotechnology Hosted Seminar by Serial Entrepreneur Nazli Azimi
|
|
From Bench to Bedside: An Entrepreneurial JourneyNazli Azimi, PharmD, PhD Bioniz Therapeutics Wednesday, April 27, 2022 |
|||||
|
Dr. Azimi holds a PharmD and PhD in pharmaceuticals. She completed a post-doctoral fellowship in Immunology at the National Institutes of Health with a focus on cytokine biology. She is the author of over 30 peer-reviewed publications in the areas of immunology, oncology, virology, and neurological disease. She is the co-inventor of a technology that covers over 50 patents. Her early roles include Staff Scientist for the National Cancer Institute and National Institutes of Health and Assistant Professor at the Fred Hutchinson Cancer Research Center in the Virology program. Dr. Azimi is a biotechnology entrepreneur with a track record of launching biopharmaceutical companies that transform innovative scientific concepts into platform technologies for discovery of novel medicines. In her latest role, Dr. Azimi was the founder, President and CEO of Bioniz Therapeutics where she led the discovery and clinical development of first-in-class molecules for treatment of auto-immune/inflammatory diseases and cancer. The company was acquired in February 2022. This seminar will be conducted in an interactive environment where Dr. Azimi will initiate the conversation by telling her story and encourage the audience to participate.
|
||||||
